Search research articles
Contact Us
Filters
Showing results (121-130 of 242) with videos related to
Page
of 25
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation
|
June 1, 1971
Typing of fibrinogen degradation products in urine in various clinical disorders
B N Bouma, U Hedner, I M Nilsson
Thrombosis and Haemostasis
|
February 3, 1987
Effects of an enzymatically depolymerized heparin as compared with conventional heparin in healthy volunteers
T Mätzsch, D Bergqvist, U Hedner, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
June 11, 1998
Clinical experience with recombinant factor VIIa
J Lusher, J Ingerslev, H Roberts, et al.
Scandinavian Journal of Urology and Nephrology
|
January 1, 1971
On fibrinolytic split products in serum and urine in uraemia
S O Larsson, U Hedner, I M Nilsson
Acta Chirurgica Scandinavica
|
June 1, 1990
Low molecular weight heparin compared with dextran as prophylaxis against thrombosis after total hip replacement
T Mätzsch, D Bergqvist, H Fredin, et al.
Nordisk Medicin
|
June 24, 1971
[Acute uremia and intravasal coagulation]
S O Larsson, U Hedner, I M Nilsson
Upsala Journal of Medical Sciences
|
January 1, 1989
Coagulation and fibrinolysis during the normal menstrual cycle
A Siegbahn, V Odlind, U Hedner, et al.
Acta Medica Scandinavica
|
June 1, 1971
On coagulation and fibrinolysis in conservatively treated chronic uraemia
S O Larsson, U Hedner, I M Nilsson
Journal of Thrombosis and Haemostasis : JTH
|
July 23, 2003
The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX
S He, M Blombäck, G Jacobsson Ekman, et al.
Thrombosis and Haemostasis
|
October 1, 1991
Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma
O Nordfang, S Valentin, T C Beck, et al.
Page
of 25
Search research articles
Search
Showing results (121-130 of 242) with videos related to
Sort By:
Page
of 25
Scandinavian Journal of Clinical and Laboratory Investigation
|
June 1, 1971
Typing of fibrinogen degradation products in urine in various clinical disorders
B N Bouma, U Hedner, I M Nilsson
Thrombosis and Haemostasis
|
February 3, 1987
Effects of an enzymatically depolymerized heparin as compared with conventional heparin in healthy volunteers
T Mätzsch, D Bergqvist, U Hedner, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
June 11, 1998
Clinical experience with recombinant factor VIIa
J Lusher, J Ingerslev, H Roberts, et al.
Scandinavian Journal of Urology and Nephrology
|
January 1, 1971
On fibrinolytic split products in serum and urine in uraemia
S O Larsson, U Hedner, I M Nilsson
Acta Chirurgica Scandinavica
|
June 1, 1990
Low molecular weight heparin compared with dextran as prophylaxis against thrombosis after total hip replacement
T Mätzsch, D Bergqvist, H Fredin, et al.
Nordisk Medicin
|
June 24, 1971
[Acute uremia and intravasal coagulation]
S O Larsson, U Hedner, I M Nilsson
Upsala Journal of Medical Sciences
|
January 1, 1989
Coagulation and fibrinolysis during the normal menstrual cycle
A Siegbahn, V Odlind, U Hedner, et al.
Acta Medica Scandinavica
|
June 1, 1971
On coagulation and fibrinolysis in conservatively treated chronic uraemia
S O Larsson, U Hedner, I M Nilsson
Journal of Thrombosis and Haemostasis : JTH
|
July 23, 2003
The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX
S He, M Blombäck, G Jacobsson Ekman, et al.
Thrombosis and Haemostasis
|
October 1, 1991
Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma
O Nordfang, S Valentin, T C Beck, et al.
Page
of 25